openPR Logo
Press release

Overview Of Heart Failure - Global Drug Forecast and Market Analysis to 2026

10-11-2017 12:40 PM CET | Health & Medicine

Press release from: Heart Failure

Market Research Report

Market Research Report

Researchmoz added Most up-to-date research on "Overview Of Heart Failure - Global Drug Forecast and Market Analysis to 2026" to its huge collection of research reports.

GlobalData estimates sales of HF therapeutics to be approximately $3.7B across the 7MM in 2016, encompassing the US, the five major European markets (5EU: France, Germany, Italy, Spain and UK), and Japan. By 2026, GlobalData expects the HF market to grow at a strong Compound Annual Growth Rate (CAGR) of 15.7%, reaching sales of $16.1B by the end of the forecast period. Chronic HF therapeutics accounted for 95.9% of the total HF market in 2015, and despite the launch of a new acute HF therapy, this figure is expected to increase slightly to 98.7% by 2026. GlobalData expects uptake of Novartis Entresto will be the strongest driver of the chronic HF and total HF markets in the 7MM, reaching peak sales of $8.6B in 2022.

Key Questions Answered

- The level of unmet needs in the HF market is significantly high. Will the pipeline drugs fulfil these unmet needs of the market? Key Opinion Leaders (KOLs) interviewed by GlobalData provide insights and highlight opportunities for drug developers.
- The HF market is crowded with cheap, generic, me-too drugs, making it a particularly difficult market to penetrate. The current late-stage pipeline consists of several chronic HF therapies, and three novel acute HF therapies. How will the market be impacted by the launch of these drugs? Which of the marketed and pipeline drugs will have the highest peak sales at the highest CAGR, and why?
- Will Entresto become the new standard-of-care in the chronic HF market? What are the main barriers a new therapy faces when entering the HF market?

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1335051

Scope

- Overview of HF, both chronic and acute, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.
- Annualized HF therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2016 and forecast for ten years to 2026.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the chronic and acute HF therapeutics markets.
- Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, and detailed analysis of late-stage pipeline drugs.
- Analysis of the current and future market competition in the global HF therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. Additionally a list of acquisition targets included in the pipeline product company list.
- Develop business strategies by understanding the trends shaping and driving the HF therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the HF therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track drug sales in the 7MM HF therapeutics market from 2016-2026.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Browse More Details @ https://www.researchmoz.us/pharmapoint-heart-failure-global-drug-forecast-and-market-analysis-to-2026-report.html

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Overview Of Heart Failure - Global Drug Forecast and Market Analysis to 2026 here

News-ID: 767899 • Views:

More Releases from Heart Failure

New Survey on PharmaPoint: Heart Failure - Global Drug Forecast and Market Analy …
Researchmoz added Most up-to-date research on "PharmaPoint: Heart Failure - Global Drug Forecast and Market Analysis to 2025" to its huge collection of research reports. GlobalData estimates sales of Heart Failure (HF) therapeutics to be approximately $3.2B across the 7MM in 2015, encompassing the US, 5EU, and Japan. The HF market will grow at a strong CAGR of 13.5% over the forecast period, reaching sales of $11.5B by 2025. The 7MM
PharmaPoint: Heart Failure - Global Drug Forecast And Market Analysis To 2025
PharmaPoint: Heart Failure - Global Drug Forecast and Market Analysis to 2025 Access Full Report: http://www.marketresearchreports.biz/analysis/774307 Summary GlobalData estimates sales of Heart Failure (HF) therapeutics to be approximately $3.2B across the 7MM in 2015, encompassing the US, 5EU, and Japan. The HF market will grow at a strong CAGR of 13.5% over the forecast period, reaching sales of $11.5B by 2025. The 7MM chronic HF market size in 2015 was $3.1B, and is

More Releases for GlobalData

GlobalData Travel and Tourism Survey 2017-2018
ReportsWeb.com published “Travel and Tourism Survey Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. "Publisher Travel and Tourism Survey 2017-2018", report analyzes travelers' opinion on the purpose of air travel and the preferred channels/devices used by them when booking air tickets. This report also examines travelers' opinions
Emeging Evolution : GlobalData Travel and Tourism Survey 2017-2018
ALBANY, NY, May 30, 2017 : "GlobalData Travel and Tourism Survey 2017-2018", report analyzes travelers opinion on the purpose of air travel and the preferred channels/devices used by them when booking air tickets. This report also examines travelers opinions with regard to the average shopping frequency, preferred travel destinations, and the average time spent at airport retail outlets. In addition, the report examines the travelers product shopping trends, and the
GlobalData Travel and Tourism Survey 2017-2018
MarketResearchReports.Biz presents this most up-to-date research on "GlobalData Travel and Tourism Survey 2017-2018" Description "GlobalData Travel and Tourism Survey 2017-2018", report analyzes travelers opinion on the purpose of air travel and the preferred channels/devices used by them when booking air tickets. This report also examines travelers opinions with regard to the average shopping frequency, preferred travel destinations, and the average time spent at airport retail outlets. In addition, the report examines the
GlobalData Travel And Tourism Survey 2017-2018
"The Report GlobalData Travel and Tourism Survey 2017-2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Travel and Tourism Market Summary "GlobalData Travel and Tourism Survey 2017-2018", report analyzes travelers opinion on the purpose of air travel and the preferred channels/devices used by them when booking air tickets. This report also examines travelers opinions with regard to the average shopping frequency, preferred travel
GlobalData: Anti-Hypertension Therapeutics - Pipeline Assessment And Market Fore …
GlobalData, the industry analysis specialist’s new report, Anti-Hypertension Therapeutics - Pipeline Assessment And Market Forecasts to 2017 is an essential source of information and analysis on the global hypertension market. The report identifies the key trends shaping and driving the global hypertension market. The report also provides insight on the competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders.
GlobalData: Insulin Pumps - Analysis, Opportunitys, Forecasts to 2016 on reports …
GlobalData’s medical equipment report, Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 provides key data, information and analysis on the global insulin pumps market. The report provides market landscape, competitive landscape and market trends information the insulin pumps market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the